BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26218492)

  • 1. The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.
    Herweijer E; Feldman AL; Ploner A; Arnheim-Dahlström L; Uhnoo I; Netterlid E; Dillner J; Sparén P; Sundström K
    PLoS One; 2015; 10(7):e0134185. PubMed ID: 26218492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study.
    Kreusch T; Wang J; Sparén P; Sundström K
    BMJ Open; 2018 Oct; 8(10):e024477. PubMed ID: 30282687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
    Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
    BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catch-up HPV Vaccination and Subsequent Uptake of Papanicolaou Testing in A State-mandated Health System.
    Chodick G; Leader AE; Larson S
    Cancer Prev Res (Phila); 2021 Apr; 14(4):415-420. PubMed ID: 33687944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
    Taniguchi M; Ueda Y; Yagi A; Ikeda S; Endo M; Tomimatsu T; Nakayama T; Sekine M; Enomoto T; Kimura T
    Vaccine; 2019 Jul; 37(32):4424-4426. PubMed ID: 31272873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country.
    Velentzis LS; Caruana M; Simms KT; Lew JB; Shi JF; Saville M; Smith MA; Lord SJ; Tan J; Bateson D; Quinn M; Canfell K
    Int J Cancer; 2017 Dec; 141(12):2410-2422. PubMed ID: 28801947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap.
    Cameron RL; Kavanagh K; Cameron Watt D; Robertson C; Cuschieri K; Ahmed S; Pollock KG
    J Epidemiol Community Health; 2017 Oct; 71(10):954-960. PubMed ID: 28756395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.
    Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
    BMC Public Health; 2016 Aug; 15():708. PubMed ID: 27488178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a Human Papillomavirus Vaccination Program within Organized Cervical Cancer Screening: Cohort Study.
    Martellucci CA; Morettini M; Brotherton JML; Canfell K; Manzoli L; Flacco ME; Palmer M; Rossi PG; Martellucci M; Giacomini G; D'Errico MM; Pasqualini F
    Cancer Epidemiol Biomarkers Prev; 2022 Mar; 31(3):588-594. PubMed ID: 35027435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mothers' screening histories influence daughters' vaccination uptake: an analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England.
    Spencer Nee Pilkington AM; Brabin L; Verma A; Roberts SA
    Eur J Cancer; 2013 Apr; 49(6):1264-72. PubMed ID: 23290788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the HPV vaccination programme have implications for cervical screening programmes in the UK?
    Beer H; Hibbitts S; Brophy S; Rahman MA; Waller J; Paranjothy S
    Vaccine; 2014 Apr; 32(16):1828-33. PubMed ID: 24530938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colposcopic performance in a birth cohort previously eligible for human papillomavirus vaccination.
    Sahlgren HAI; Elfgren K; Sparen P; Elfstrom MK
    Am J Obstet Gynecol; 2022 May; 226(5):704.e1-704.e9. PubMed ID: 34954217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Cohort Study of Young Women Spontaneously Choosing to Be Vaccinated against HPV: Outcomes from Their First Cervical Cancer Screening Test.
    Del Mistro A; Battagello J; Weis L; Bressan V; Selle V; Ramigni M; Dal Zotto A; Maggiolo A; Gori S; Frayle H; Zappa M; Zorzi M; The Consensus Study Veneto Working Group
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33809436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.
    Kumakech E; Andersson S; Wabinga H; Musubika C; Kirimunda S; Berggren V
    BMC Womens Health; 2017 Jun; 17(1):40. PubMed ID: 28576143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data.
    Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Nicoll S; Robertson C
    Br J Cancer; 2016 Mar; 114(5):576-81. PubMed ID: 26794278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.
    Kim J; Bell C; Sun M; Kliewer G; Xu L; McInerney M; Svenson LW; Yang H
    CMAJ; 2016 Sep; 188(12):E281-E288. PubMed ID: 27378467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Consensus Project: Participation in cervical cancer screening by the first cohorts of girls offered HPV vaccination at age 15-16 years in Italy.
    Visioli CB; Giorgi Rossi P; Armaroli P; Iossa A; Rizzolo R; Bonelli LA; Venturino E; Carozzi FM; Bisanzi S; De Marco L; Giordano L; Camussi E; Del Mistro A; Zappa M
    J Med Screen; 2023 Sep; 30(3):142-149. PubMed ID: 36999190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papilloma virus (HPV) prevalence upon HPV vaccination in Swedish youth: a review based on our findings 2008-2018, and perspectives on cancer prevention.
    Du J; Ährlund-Richter A; Näsman A; Dalianis T
    Arch Gynecol Obstet; 2021 Feb; 303(2):329-335. PubMed ID: 33247317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between prior HPV4 vaccine doses and cervical cancer screening participation.
    Boone SD; Pinkston CM; Baumgartner KB; Baumgartner RN; Harper SM; Bonham AJ; Paynter CA; Harper DM
    Cancer Epidemiol; 2016 Jun; 42():108-14. PubMed ID: 27100836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands.
    Mollers M; Lubbers K; Spoelstra SK; Weijmar-Schultz WC; Daemen T; Westra TA; van der Sande MA; Nijman HW; de Melker HE; Tami A
    BMC Public Health; 2014 Mar; 14():288. PubMed ID: 24679163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.